Allogene Therapeutics appoints Timothy Moore as chief technical officer

Allogene Therapeutics announced the appointment of Timothy Moore to executive VP, chief technical officer effective April 24. The selection of Moore, the former executive VP, technical operations of Kite Pharma responsible for the global development of two of the most commercially successful autologous CAR T manufacturing processes in the industry, reinforces the company’s mission to being the first to bring an AlloCAR T product to market. Moore succeeds Alison Moore, who intends to serve as a consultant to Allogene.